Jeffrey C. Pepe - Insider Trading & Ownership

Entity
Individual
Location
C/O Silverback Therapeutics, Inc., 500 Fairview Avenue N, Suite 600, Seattle, WA
Summary
The estimated net worth of Jeffrey C. Pepe is at least $198K dollars as of September 8, 2022. Jeffrey C. Pepe is the Interim CEO and GC of Silverback Therapeutics, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $198K.
All Insider Reports
All Insider Reports

Ownership of Jeffrey C. Pepe

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SPRY ARS Pharmaceuticals, Inc. Interim CEO and GC $198K Sep 2, 2022

There are no insider transactions reported by Jeffrey C. Pepe